Showing results (11-20 of 84) with videos related to
Sort By:
Pageof 9
Cancer Treatment Reviews|August 25, 2004
New approaches to prevent intestinal toxicity of irinotecan-based regimensAndrea Alimonti, Alain Gelibter, Ida Pavese, et al.Cancers|January 10, 2019
Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal CancerCristina Raimondi, Chiara Nicolazzo, Francesca Belardinilli, et al.Acta Oncologica (Stockholm, Sweden)|December 24, 2003
Docetaxel in advanced gastric cancer--review of the main clinical trialsSerena Di Cosimo, Gianluigi Ferretti, Nicola Fazio, et al.World Journal of Gastroenterology|August 1, 2013
First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancerVanja Vaccaro, Emilio Bria, Isabella Sperduti, et al.Oncotarget|May 16, 2022
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational studyCarolina Sciortino, Valentina Viglialoro, Massimo Nucci, et al.Expert Opinion on Therapeutic Targets|August 9, 2011
Emerging pathways and future targets for the molecular therapy of pancreatic cancerVanja Vaccaro, Davide Melisi, Emilio Bria, et al.Recenti Progressi in Medicina|January 8, 2020
[Immunotherapy in non-small cell lung cancer patients: back to the future.]Michela Roberto, Andrea Botticelli, Fabiana Cecere, et al.Cancer|June 29, 2004
Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinomaMichele Milella, Alain Gelibter, Serena Di Cosimo, et al.Diagnostics (Basel, Switzerland)|December 24, 2021
Comparison of Two Blood-Based Genotyping Tests to Investigate the KRAS G12C Mutation in Patients with Non-Small-Cell Lung Cancer at Failure of First-Line TreatmentsChiara Nicolazzo, Alain Gelibter, Irene Bottillo, et al.Experimental Hematology|March 9, 2004
Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysisIzhar Hardan, Rachel Rothman, Alain Gelibter, et al.Pageof 9